Wuppertal, Germany

Andreas Göller

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 13.3

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
5 patents (USPTO):

Title: The Innovative Contributions of Andreas Göller

Introduction

Andreas Göller is a notable inventor based in Wuppertal, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for the treatment of various diseases. With a total of five patents to his name, Göller continues to push the boundaries of innovation in healthcare.

Latest Patents

Göller's latest patents focus on substituted piperidinyl tetrahydroquinolines. These compounds are designed for the treatment and prevention of diseases, specifically targeting diabetic microangiopathies and diabetic ulcers. The applications highlight their potential in promoting wound healing for diabetic foot ulcers and addressing complications such as diabetic heart failure and peripheral vascular disorders. The innovative nature of these compounds showcases Göller's commitment to improving patient outcomes through advanced medicinal solutions.

Career Highlights

Andreas Göller is currently associated with Bayer Pharma Aktiengesellschaft, a leading global pharmaceutical company. His work at Bayer has allowed him to collaborate with some of the brightest minds in the industry, contributing to groundbreaking research and development in pharmaceuticals. Göller's expertise in medicinal chemistry has positioned him as a key player in the field.

Collaborations

Throughout his career, Göller has worked alongside talented colleagues, including Eva Maria Becker-Pelster and Philipp Buchgraber. These collaborations have fostered an environment of innovation and creativity, leading to the successful development of new therapeutic agents.

Conclusion

Andreas Göller's contributions to the field of medicinal chemistry are significant and impactful. His innovative work on substituted piperidinyl tetrahydroquinolines demonstrates his dedication to advancing healthcare solutions. As he continues to develop new treatments, Göller's influence in the pharmaceutical industry is sure to grow.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…